Potential target for reversing drug resistance in ovarian cancer identified
For the 314,000 people diagnosed with ovarian cancer each year, platinum-based drugs such as cisplatin…
Browsing: ovarian cancer
Ovarian cancer: New biological markers found that may predict which patients won’t respond to chemotherapy
Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School…
CAR-T immune therapy attacks ovarian cancer in mice with a single dose
CAR-T immune therapies could be effective against solid tumours if the right targets are identified,…
Signaling between cancer and mesothelial cells promotes ovarian cancer tumourigenesis and immune evasion
Ovarian cancer is the fourth leading cause of cancer mortality amongst women and is characterized…
Why obesity makes ovarian cancer more deadly
Most women with ovarian cancer are diagnosed with the most advanced form of the disease.…
New approach to adoptive T-cell therapy shows promise for boosting immune response in ovarian cancer
Researchers from Roswell Park Comprehensive Cancer Center, USA, report that a new approach to immunotherapy…
Synoptic reporting improves pretreatment CT for advanced ovarian cancer
According to an accepted manuscript published in the American Journal of Roentgenology (AJR), a synoptic report improved…
Previously unidentified proteins suggest new way to diagnose ovarian cancer
A study led by Nagoya University in Japan has identified three previously unknown membrane proteins…
Research team assesses addition of complement inhibitor drug to immunotherapy for ovarian cancer
Researchers at Roswell Park Comprehensive Cancer Center, USA, have launched a phase 2 clinical trial…
Cancer risk among women with polycystic ovary syndrome doubles after menopause
Women with polycystic ovary syndrome (PCOS) are not at any greater risk of ovarian cancer…